on 12 Jan 2024
TM5 Status
LIVE/REGISTRATION/Issued and Active
Your registration has been issued and is active. You can now use the TM5 mark.
Last Applicant/ Owned by
PRINCIPIA BIOPHARMA INC.
55 Corporate DriveBridgewater NJ 08807
US
Serial Number
2109926 filed on 5th Apr 2021
Registration Number
TMA1218094 registered on 12th Jan 2024
Registration expiry Date
5th Apr 2031Correspondent Address
SMART & BIGGAR LP
SCOTIA PLAZA40 KING STREET WEST40th FLOORTORONTO
ONTARIO
CA
M5H3Y2
Trademark usage description
pharmaceutical preparations for the prevention and treatment of immune-mediated namely immune thrombocytopenia, warm auto-immune hemolytic anemia, igg Read More11
2109926
Trademark
Action Taken | Status |
---|---|
Submitted for opposition 22 on 29th Aug 2022 | Search Recorded |
Submitted for opposition 20 on 29th Aug 2022 | Examiner's First Report |
Submitted for opposition 135 on 28th Jul 2022 | Amendment to Application |
Submitted for opposition 256 on 28th Mar 2022 | Notification of Possible Opposition Sent |
Submitted for opposition 48 on 16th Jul 2021 | Agent Changed |
Submitted for opposition 257 on 27th May 2021 | Designation Notification - Madrid Protocol |
Submitted for opposition 1 on 26th May 2021 | Created |
Submitted for opposition 31 on 26th May 2021 | Formalized |
Submitted for opposition 30 on 5th Apr 2021 | Filed |
Submitted for opposition 228 on 5th Apr 2021 | International Registration |